Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
HKD 0.91
(0.0%)
HKD 0.91
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.79 Billion CNY | -4.41% |
| 2022 | 1.87 Billion CNY | 23.04% |
| 2021 | 1.52 Billion CNY | 7.29% |
| 2020 | 1.42 Billion CNY | 10.93% |
| 2019 | 1.28 Billion CNY | 26.6% |
| 2018 | 1.01 Billion CNY | 10.91% |
| 2017 | 911.95 Million CNY | 20.75% |
| 2016 | 755.22 Million CNY | 4.38% |
| 2015 | 723.52 Million CNY | 142.86% |
| 2014 | 297.92 Million CNY | -0.32% |
| 2013 | 298.87 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.96 Billion CNY | 9.43% |
| 2023 Q4 | 1.79 Billion CNY | 0.44% |
| 2023 FY | 1.79 Billion CNY | -4.41% |
| 2023 Q2 | 1.78 Billion CNY | -4.82% |
| 2022 FY | 1.87 Billion CNY | 23.04% |
| 2022 Q2 | 1.55 Billion CNY | 2.32% |
| 2022 Q4 | 1.87 Billion CNY | 20.25% |
| 2021 Q2 | 1.52 Billion CNY | 7.65% |
| 2021 FY | 1.52 Billion CNY | 7.29% |
| 2021 Q4 | 1.52 Billion CNY | -0.33% |
| 2020 FY | 1.42 Billion CNY | 10.93% |
| 2020 Q4 | 1.42 Billion CNY | 4.62% |
| 2020 Q2 | 1.35 Billion CNY | 6.03% |
| 2019 FY | 1.28 Billion CNY | 26.6% |
| 2019 Q4 | 1.28 Billion CNY | 9.26% |
| 2019 Q2 | 1.17 Billion CNY | 15.87% |
| 2018 Q4 | 1.01 Billion CNY | 6.25% |
| 2018 FY | 1.01 Billion CNY | 10.91% |
| 2018 Q2 | 951.96 Million CNY | 4.39% |
| 2017 Q4 | 911.95 Million CNY | 14.95% |
| 2017 Q2 | 793.33 Million CNY | 5.05% |
| 2017 FY | 911.95 Million CNY | 20.75% |
| 2016 Q2 | 730.7 Million CNY | 0.99% |
| 2016 Q4 | 755.22 Million CNY | 3.36% |
| 2016 FY | 755.22 Million CNY | 4.38% |
| 2015 Q4 | 723.52 Million CNY | 110.3% |
| 2015 FY | 723.52 Million CNY | 142.86% |
| 2015 Q2 | 344.04 Million CNY | 15.48% |
| 2014 Q4 | 297.92 Million CNY | 0.0% |
| 2014 FY | 297.92 Million CNY | -0.32% |
| 2013 FY | 298.87 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -97.543% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 92.038% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -39.267% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | 14.437% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -274.936% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 37.985% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 36.601% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -3.78% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -112.407% |
| SSY Group Limited | 11.96 Billion HKD | 85.019% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -29.088% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 48.589% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.34% |